Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > OMGA Omega Therapeutics > Detailed Quotes

OMGA Omega Therapeutics

5.370
+0.350+6.97%
Close 10/04 16:00 ET
High
5.501
Open
5.020
Turnover
220.53K
Low
5.010
Pre Close
5.020
Volume
42.04K
Market Cap
256.97M
P/E(TTM)
Loss
52wk High
31.410
Shares
47.85M
P/E(Static)
Loss
52wk Low
1.975
Float Cap
94.14M
Bid/Ask %
-8.11%
Historical High
31.410
Shs Float
17.53M
Volume Ratio
0.43
Historical Low
1.975
Dividend TTM
--
Div Yield TTM
--
P/B
1.63
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.24%
Amplitude
9.79%
Avg Price
5.246
Lot Size
1
Float Cap
94.14M
Bid/Ask %
-8.11%
Historical High
31.410
Shs Float
17.53M
Volume Ratio
0.43
Historical Low
1.975
Dividend TTM
--
P/B
1.63
Dividend LFY
--
Turnover Ratio
0.24%
Amplitude
9.79%
Avg Price
5.246
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Omega Therapeutics, Inc. engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.
CEO: Mr. Mahesh Karande
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...